US 9132174
Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
granted A61KA61K31/519A61K31/7048
Quick answer
US patent 9132174 (Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)) held by Anchored RSK3 Inhibitors, LLC expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Anchored RSK3 Inhibitors, LLC
- Grant date
- Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/519, A61K31/7048, A61K31/713, A61K38/005